Skip to main content

Table 1 Demographic and histologic characteristics of HCC patients

From: In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma

Characteristics

n = 131

Age (yrs)

55 (48–62)

Gender

 Female (%)

24 (18.32%)

 Male (%)

107 (81.68%)

HBeAg

 Positive(%)

26 (19.74%)

 Negative(%)

77 (58.77%)

 Not available(%)

28 (21.37%)

Serum HBsAga (IU/mL)

 <250

35 (33.98%)

 >250

68 (66.02%)

Serum HBV DNAb (IU/mL)

 <500

78 (68.42%)

 >500

36 (31.58%)

Diagnostic markers

 Ki-67

131 (100%)

 Hep-par1

127 (96.95%)

 GPC-3

128 (97.71%)

 GSc

125 (96.15%)

 HSP70d

124 (96.88%)

α-fetoprotein (ng/ml)

39.9 (8.0–522.2)

Alanine transferase ALT (U/L)

31.0 (21.0–49.3)

Necro-Inflammation (G1,G2,G3,NA)

17:66:30:18

Fibrosis (S1,S2,S3,S4,NA)

5:6:4:98:18

Tumor Differentiation (1,2,3)

12:98:21

MVI (M0,M1,M2)

60: 44: 27

Satellite nodule

7 (5.34%)

Nodule in nodule

27 (20.61%)

Recurrence

 Yes

68 (51.90%)

 No

61 (46.56%)

 death

2 (1.52%)

  1. Data expressed as the median (interquartile range)
  2. a. 28 cases missing serum HBsAg information;
  3. b. 17 cases missing serum HBV DNA information;
  4. c. 1 cases missing IHC GS information;
  5. d. 3 case missing IHC Hsp70 information;